Experimental drug may slow the progression of atherosclerosi

An experimental drug already tested as a potential treatment for cancer, lung disease, and Alzheimer's disease may slow the progression of atherosclerosis that leads to heart disease, a new study shows.

Related Keywords

New York , United States , Peik Sean Chong , Simon Koplev , Minji Jeon , Christopher Hill , Natalia Eberhardt , Adam Ghotbi , Ravneet Kaur , Yannick Cyr , Peter Faries , Avi Maayan , Ken Sakurai , Chiara Giannarelli , Pauline Mury , Lily Ramsey , Raphael Soler , Nicolas Fernandez , Sonum Naidu , Kathrynj Moore , Roza Shamailova , Zahi Fayad , Swathy Sajja , Letizia Amadori , Adeeb Rahman , Claudia Calcagno , Nayaab Kahn , Langone Health , Library Of Integrated Network , Giannarelli Lab , National Institutes Of Health , Icahn School Of Medicine At Mount Sinai , Grossman School Of Medicine , Nature Cardiovascular Research , National Institutes , Integrated Network Based Cellular Signatures , Icahn School , Mount Sinai , Dawn Fernandez , Avi Ma Ayan , Cancer , Heart , Heart Disease , Inflammation , Lzheimer 39s Disease , Atherosclerosis , Flood , Blood Vessels , Hronic , Genes , Heart Attack , Immune Response , Nterleukin , Ung Disease , Medicine , Research , Stroke ,